193 related articles for article (PubMed ID: 16022955)
1. Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G; Macchia A; Marfisi R; Franzosi MG; Maggioni AP; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
J Am Coll Cardiol; 2005 Jul; 46(2):277-83. PubMed ID: 16022955
[TBL] [Abstract][Full Text] [Related]
2. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
[TBL] [Abstract][Full Text] [Related]
3. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis.
Ovbiagele B; Saver JL; Lynn MJ; Chimowitz M;
Neurology; 2006 May; 66(9):1344-9. PubMed ID: 16682665
[TBL] [Abstract][Full Text] [Related]
4. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
[TBL] [Abstract][Full Text] [Related]
5. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
[TBL] [Abstract][Full Text] [Related]
7. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
[TBL] [Abstract][Full Text] [Related]
8. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
[TBL] [Abstract][Full Text] [Related]
10. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
[TBL] [Abstract][Full Text] [Related]
12. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
Persson M; Hedblad B; Nelson JJ; Berglund G
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure].
Kuch M; Janiszewski M; Janiszewski M; Braksator W; Mamcarz A; Sadkowska K; Kuch J; Dłuzniewski M
Pol Merkur Lekarski; 2006 Mar; 20(117):285-8. PubMed ID: 16780256
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
[TBL] [Abstract][Full Text] [Related]
15. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
[TBL] [Abstract][Full Text] [Related]
16. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study.
Pajunen P; Rissanen H; Härkänen T; Jula A; Reunanen A; Salomaa V
Diabetes Metab; 2010 Nov; 36(5):395-401. PubMed ID: 20673644
[TBL] [Abstract][Full Text] [Related]
19. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
20. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.
Vaccaro O; Eberly LE; Neaton JD; Yang L; Riccardi G; Stamler J;
Arch Intern Med; 2004 Jul; 164(13):1438-43. PubMed ID: 15249353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
